Has Matthew Deren, MD received payments from drug or device companies?

Yes. Drug and device makers reported $10,094 in general payments to Matthew Deren, MD across 107 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Matthew Deren, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Matthew Deren, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Matthew Deren, MD

Adult Reconstructive Orthopaedic Surgery · Cleveland, OHNPI 1043503279

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (55.9%), travel and lodging and consulting fees — rather than concentrated in one kind of arrangement. Stryker accounts for 66.6% of it on its own, with 9 other manufacturers making up the rest. 2025 is the largest year on record at $2,894, 2.1 times the $1,366 reported in 2019. That places this record below the midpoint for adult reconstructive orthopaedic surgery clinicians in OH, where the typical reported total is $10,094.

$10,094in general payments, 2019–2025

Across 107 payments — averaging $94.34 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Stryker$7K
Zimmer Biomet$2K
Medical Device Business Services, Inc.$269
Johnson & Johnson$179
Smith+Nephew$162
Medtronic$147
plus $288 from 4 others

$110,195in research payments, 2019–2025

Across 17 payments — averaging $6482.04 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Stryker$96K
Zimmer Biomet$15K

What the payments were for

Consulting fees$1,46014%
Travel & lodging$2,98830%
Food & beverage$5,64656%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Stryker	55	$6,720
Zimmer Biomet	28	$2,330
Medical Device Business Services, Inc.	9	$269
Johnson & Johnson	6	$179
Smith+Nephew	3	$162
Medtronic	2	$147
Onkos Surgical, Inc.	1	$125
Convatec Inc.	1	$100
Peter Brasseler Holdings, LLC	1	$33
Pacira Pharmaceuticals Incorporated	1	$31

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

MAKO$2,252
CORE$1,460
SYSTEM 9 CD NXT$1,460
TRIATHLON$933
ROSA$700
Arcos$484
Persona$477
INSIGNIA$147
PATIENT-FITTED TMJ RECONSTRUCTIVE PROSTHESIS SYSTEM$140
ELEOS LIMB SALVAGE SYSTEM$125
Velys$115
REAL INTELLIGENCE$104
GMRS$102

How this compares

$10,094 in reported general payments places this provider in the 50th percentile of 59 adult reconstructive orthopaedic surgery providers in Ohio.

See all adult reconstructive orthopaedic surgery providers in Ohio →

Medicare billing

Part B allowed, 2024

$188,182

Medicare patients

301

Services billed

553

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Celecoxib	17	$389
Mupirocin	50	$262
Amoxicillin	17	$20

Paid to pharmacies, not to this prescriber.

Other adult reconstructive orthopaedic surgery in Cleveland

Viktor KrebsCleveland$7.5M
Nicolas PiuzziCleveland$1.2M
Michael BloomfieldCleveland$321K
Trevor MurrayCleveland$192K
James VoosCleveland$166K
Peter SuraceCleveland$146K
Kim StearnsCleveland$80K
John McLaughlinCleveland$79K
Mark DenzineCleveland$31K
Michael KolczunCleveland$22K

See the full list for Ohio →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →